Category Archives: Pharmaceutical Pricing and Procurement

Richtman Interview – Podcast June 10, 2019

Debunking The Myths About Social Security. Democratic Perspective welcomes back Max Richtman, President and CEO of the National Committee to Preserve Social Security and Medicare to talk about fixing Social Security. He begins by talking about the myth that Social … Continue reading

Posted in Economic Stimulus, Entitlements, Government, Interviews, Medicare, Minimum Wage, National Politics, Pharmaceutical Pricing and Procurement, Social Security | Tagged | Comments Off on Richtman Interview – Podcast June 10, 2019

David Brushwood Interview – Podcast January 22, 2018

Reducing Drug Prices. The Democratic Perspective team revisits the high cost of pharmaceuticals with one of our own colleagues – Pharmacology professor and consultant, David Brushwood. Dave helps explain how our drug prices became the highest in the world and … Continue reading

Posted in Capitalism, Government, Health Care, Health Insurance, Medical Science and Technology, National Politics, Pharmaceutical Pricing and Procurement, Public Health Policy, Regulatory Agencies | Tagged , | Comments Off on David Brushwood Interview – Podcast January 22, 2018

Max Richtman Interview — Podcast November 20, 2017

The Republican Flim-flam Continues: First They Reduce Taxes for the 1% Enough To Ensure a 1.5 Trillion Dollar Federal Budget Deficit, Then They Cut Billions From Social Security and Medicare To Help Reduce the Deficit They Just Created.  Max Richtman, … Continue reading

Posted in Affordable Care Act, Corporate Welfare, Corruption, Democratic Governance, Domestic Policy, Entitlements, Health Care, Health Care Policy, Health Insurance, Interviews, Medicaid, Medicare, Pharmaceutical Pricing and Procurement, Podcasts, Privatization, Public Health Policy, Social Insurance, Social Security, Special Interest Legislation, Tax Revenues, Taxation, Welfare | Tagged , , , , , , , , , , | Comments Off on Max Richtman Interview — Podcast November 20, 2017

David Brushwood Interview — Podcast May 1, 2017

Martin Shkreli Isn’t the Only Profiteer in the Pharmaceutical Industry: Why Does the U.S., Alone Among Developed Countries, Allow Life-Saving Prescription Drugs To Be Priced Beyond the Reach Of Many Of the Patients Who Need Them? David Brushwood, professor emeritus of Pharmaceutical Outcomes … Continue reading

Posted in Affordable Care Act, Corruption, Health Care, Health Care Delivery, Health Care Policy, Health Insurance, Interviews, Medicaid, Medicare, National Politics, Pharmaceutical Pricing and Procurement, Podcasts, Public Health Policy | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on David Brushwood Interview — Podcast May 1, 2017